Related Experiment Video
Updated: Oct 21, 2025

08:40
Author Spotlight: A Novel 3D-Printed Titanium Implant for Minimally Invasive Treatment of Hip Dysplasia in Young Dogs
Published on: April 19, 2024
3.0K
Hypertrophic osteodystrophy in dogs
1Small Animal Surgery, BluePearl Veterinary Partners, Overland Park, Kansas, USA.
The Journal of Small Animal Practice
|September 7, 2021
Summary
Hypertrophic osteodystrophy (HOD) is a painful orthopedic condition in young dogs with unknown causes. Diagnosis involves clinical signs and radiographic evidence of a "double physis," with treatment focusing on supportive care and pain management.
Area of Science:
- Veterinary Orthopedics
- Canine Pathology
Background:
- Hypertrophic osteodystrophy (HOD) is an uncommon orthopedic disease affecting young, growing dogs.
- The etiology of HOD remains unknown, with theories including viral infections, vaccinations, hereditary factors, and autoimmune disorders.
Purpose of the Study:
- To summarize the clinical presentation, diagnostic methods, treatment strategies, and prognosis for canine hypertrophic osteodystrophy.
Main Methods:
- Clinical sign assessment for suspicion of HOD.
- Radiographic confirmation using the characteristic "double physis" finding.
- Review of current treatment protocols and prognostic indicators.
Main Results:
- Affected dogs exhibit lameness, lethargy, fever, and limb swelling.
- Radiographs reveal a radiolucent line parallel to the physis, confirming HOD.
- Treatment success varies with severity, with mild to moderate cases having favorable prognoses.
Conclusions:
- Early diagnosis and supportive care are crucial for managing hypertrophic osteodystrophy in dogs.
- Prognosis is favorable for mild to moderate cases, but guarded for severely affected individuals.
- Further research into HOD etiology is warranted to improve preventative strategies.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
96
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
96
Bone Disorders
4.3K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.3K
Osteoclasts in Bone Remodeling
3.4K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.4K
Bone Remodeling
38.8K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.8K
Hormones and Bone Tissue
3.2K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.2K

